Literature DB >> 6603466

The synthesis of vitamin D metabolites by human melanoma cells.

T L Frankel, R S Mason, P Hersey, E Murray, S Posen.   

Abstract

Two melanin-producing human melanoma cell lines originally established from fresh surgical specimens were incubated with 25 hydroxyvitamin D3 (25 OHD3). Both cell lines produced material comigrating with 1,25 dihydroxy-vitamin D3 (1,25(OH)2D3) and 24,25 dihydroxyvitamin D3 (24,25(OH)2D3) in straight and reverse phase high performance liquid chromatography systems and displacing the relevant labeled ligands in competitive binding assays. The material designated 1,25(OH)2D3 was found almost entirely within the cells, whereas 24,25(OH)2D3 was evenly distributed between cells and medium. The synthesis of dihydroxylated materials was time dependent and was not observed if the cells were boiled before incubation with 25 OHD3. Preincubation with 1,25(OH)2D3 caused an increase in the synthesis of 24,25(OH)2D3 and a decrease in the synthesis of 1,25(OH)2D3. Michaelis-Menten constant (Km) values were 1.4 X 10(-9) mol/liter 25 OHD3 for the 1-alpha-hydroxylase enzyme and 72 X 10(-9) mol/liter for 24-hydroxylase. These studies constitute further evidence for the extrarenal synthesis of 1,25(OH)2D3. The suppressibility of 1 alpha-hydroxylase by preincubation with 1,25(OH)2D3 suggests a regulatory function for this system in the skin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603466     DOI: 10.1210/jcem-57-3-627

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms.

Authors:  Joel Pinczewski; Andrzej Slominski
Journal:  Exp Dermatol       Date:  2010-10       Impact factor: 3.960

Review 2.  Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Wojciech Jóźwicki; Anton M Jetten; Rebecca S Mason; Robert C Tuckey; Craig A Elmets
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

3.  1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation.

Authors:  D D Bikle; M K Nemanic; E Gee; P Elias
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

4.  Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression.

Authors:  Anna A Brożyna; Wojciech Jóźwicki; Zorica Janjetovic; Andrzej T Slominski
Journal:  Hum Pathol       Date:  2012-09-17       Impact factor: 3.466

5.  Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytes.

Authors:  D A Fetchick; D R Bertolini; P S Sarin; S T Weintraub; G R Mundy; J F Dunn
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 6.  Relevance of Vitamin D in Melanoma Development, Progression and Therapy.

Authors:  Anna A Brożyna; Robert M Hoffman; Andrzej T Slominski
Journal:  Anticancer Res       Date:  2020-01       Impact factor: 2.480

Review 7.  Vitamin D Metabolism Revised: Fall of Dogmas.

Authors:  Roger Bouillon; Dan Bikle
Journal:  J Bone Miner Res       Date:  2019-10-29       Impact factor: 6.741

8.  Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).

Authors:  Robyn P M Saw; Bruce K Armstrong; Rebecca S Mason; Rachael L Morton; Kerwin F Shannon; Andrew J Spillane; Jonathan R Stretch; John F Thompson
Journal:  BMC Cancer       Date:  2014-10-24       Impact factor: 4.430

9.  Physiologic and pathophysiologic roles of extra renal CYP27b1: Case report and review.

Authors:  Daniel D Bikle; Sophie Patzek; Yongmei Wang
Journal:  Bone Rep       Date:  2018-02-26

10.  Calcitriol and cancer therapy: A missed opportunity.

Authors:  Donald L Trump
Journal:  Bone Rep       Date:  2018-06-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.